dokumendiregister.ee
Sissetulev kiriAvalik

Järelepärimine

Ravimiamet · 19. august 2025
Viit
RST-1/4289-1
Registreeritud
19. august 2025
Dokumendi liik
Sissetulev kiri
Adressaat
Sumitomo Seika
Saabumis/saatmisviis
e-post
Funktsioon
RST Ravimistatistika tegemine
Sari
RST-1 Ravimistatistika alane kirjavahetus
Toimik
RST-1/2025
Vastutaja
Janne Sepp (RA, Peadirektori asetäitja valdkond, Ravimiohutuse osakond, Statistikabüroo)
Lahendamise tähtaeg
13. august 2025

Failid

Sisu (failidest)

Saatja: "アンジェル アルベルト ヌネズ マグロ" <[email protected]> Saaja: "Ravimiamet" <[email protected]> Teema: RE: Data about Quetiapine and Etoricoxib Kuupäev: 2025-07-29 05:51 Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Dear Ravimiamet My name is Alberto Nunez and I belong to sales department of gas and chemical division in Sumitomo Seika Japan I am looking for some data about the consumption (both amount and sales) of the bellow medicines in Estonia * Quetiapine (ATC: N05AH04) * Etoricoxib (ATC: M01AH05) I wonder if there is any source of raw data of medicine consumption in Estonia. If so, would you please let me know how to access? Thank you very much for your time Alberto _____ Dr Angel Alberto Núñez Magro Phd MBA Msc BEng. Chemical and gas division Sales manager Sumitomo Seika 1-13-5 Kudan kita, Chiyoda-ku, Tokyo 102-0073 <Tel:+81-80-> Tel:+81-80-8318-1659 Linkedin: <https://www.linkedin.com/in/angelalbertonunezmagro/> https://www.linkedin.com/in/angelalbertonunezmagro/ Mail: <mailto:[email protected]> [email protected] _____
Allikas: Ravimiamet dokumendiregister →